EUVIMEDEUVIMED entdecken
Crossref

Empagliflozin May Regresses Carotid Intima-Media Thickness and Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes Mellitus

İsa Ardahanli

Lokman Hekim Health Sciences · 2021

DOI: 10.14744/lhhs.2021.80001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lokman Hekim Health Sciences, 2021. Verfasst von İsa Ardahanli. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Changes in epicardial adipose tissue (EAT) and carotid intima-media thickness (CIMT), which are markers of subclinical atherosclerosis, were investigated in patients with type-2 diabetes mellitus (DM) initiated with empagliflozin.

Methods

Thirty-seven patients with type-2 DM were included in this study. Empagliflozin was administered to all patients within the indication, and EAT and CIMT measurements were performed. After an average of 6 months of treatment, the effects of empagliflozin on EAT and CIMT were evaluated through remeasurements.

Results

The mean age of the study group was 56.95±11.61 years, and 56.8% (n=21) of the participants were women. The mean duration of DM was 8.6±3.3 years. Significant reductions were found in weight, waist circumference, body mass index, and systolic and diastolic blood pressure at the treatment initiation and post-treatment evaluation (p

Zitieren

APA

Ardahanli, İ. (2021). Empagliflozin May Regresses Carotid Intima-Media Thickness and Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes Mellitus. Lokman Hekim Health Sciences. https://doi.org/10.14744/lhhs.2021.80001

Vancouver

Ardahanli İ. Empagliflozin May Regresses Carotid Intima-Media Thickness and Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes Mellitus. Lokman Hekim Health Sciences. 2021. doi:10.14744/lhhs.2021.80001

BibTeX
@article{Ardahanli2021,
  author = {Ardahanli, İsa},
  title = {Empagliflozin May Regresses Carotid Intima-Media Thickness and Epicardial Adipose Tissue Volume in Patients with Type 2 Diabetes Mellitus},
  journal = {Lokman Hekim Health Sciences},
  year = {2021},
  doi = {10.14744/lhhs.2021.80001}
}
Kostenlos starten →